What is immunotherapy and does it work for Multiple Myeloma

Immunotherapy and Multiple Myeloma: What You Need to Know

What Is Immunotherapy?

Immunotherapy is a type of cancer treatment that works by awakening and strengthening your own immune system to recognize and attack cancer cells. Rather than using chemotherapy drugs that poison all fast-growing cells, immunotherapy teaches your body's natural defenses to do the fighting.

Here's how it works in general:

The Basic Problem: Cancer cells are clever—they hide from your immune system by putting up "stop signals" on their surface. These signals tell your T cells (a type of white blood cell that kills cancer) to ignore the tumor and leave it alone.

How Immunotherapy Helps: Different immunotherapy approaches remove these "brakes" or boost your immune system in other ways, so your T cells can finally recognize myeloma cells as dangerous invaders and destroy them.

---

Does Immunotherapy Work for Multiple Myeloma?

Yes—but it's typically used in specific situations, not as a first-line treatment for everyone.

According to the NCCN Guidelines for Patients: Multiple Myeloma, immunotherapy drugs are an important part of the treatment toolkit for myeloma. Here's what you should know:

When Immunotherapy Is Used for Myeloma

For newly diagnosed patients: Immunotherapy is often combined with other drugs as part of multi-drug therapy. Common combinations include:

• A monoclonal antibody (like daratumumab or isatuximab) that attaches to myeloma cells and marks them for destruction
• A proteasome inhibitor (like bortezomib) that blocks proteins keeping myeloma cells alive
• An immunomodulator (like lenalidomide) that boosts immune function
• A corticosteroid (like dexamethasone) that reduces inflammation

For relapsed or resistant myeloma: If your myeloma comes back or stops responding to initial treatment, immunotherapy becomes even more important. According to NCCN Guidelines, CAR T-cell therapy (a specialized immunotherapy) is a preferred treatment option for patients who've tried at least 1-2 other therapies.

Types of Immunotherapy Used in Myeloma

The NCCN Guidelines describe several immunotherapy approaches available for myeloma patients:

1. Monoclonal Antibodies - These are artificial antibodies that attach to specific proteins on myeloma cells, essentially putting a "target" on them so your immune system can find and destroy them.

2. CAR T-Cell Therapy - This is a more advanced approach where doctors remove your own T cells, reprogram them in a laboratory to better recognize myeloma cells, and then return them to your body to fight the cancer. FDA-approved CAR T therapies for myeloma include Abecma and Carvykti.

3. Bispecific Antibodies - These newer drugs have two "arms"—one that grabs onto a myeloma cell and another that grabs onto a T cell, essentially bringing them together so the T cell can attack the myeloma cell. Examples include elranatamab (Elrexfio) and teclistamab (Tecvayli).

4. Immunomodulators - Drugs like lenalidomide (Revlimid) and pomalidomide (Pomalyst) enhance your immune system's ability to recognize and attack myeloma cells.

---

Important Context: Why Immunotherapy Matters for Myeloma

According to the NCCN Guidelines, while multiple myeloma cannot currently be cured, new treatments—including immunotherapies—are giving patients more hope and more years to live. For many people, myeloma is becoming a chronic condition they can live with for years rather than a rapidly fatal disease.

The guidelines emphasize that there are many treatment options available. If one therapy doesn't work, you can try a different one. This is especially important because myeloma often develops resistance to treatments over time, making a diverse toolkit of options crucial.

---

Questions to Ask Your Oncologist

Since immunotherapy approaches vary based on your specific situation, consider asking your care team:

1. Is immunotherapy part of my treatment plan? If so, which type and why is it recommended for my specific myeloma?

2. What monoclonal antibodies or other immunotherapy drugs are you recommending, and what do they target on my myeloma cells?

3. If my myeloma comes back or becomes resistant to my current treatment, would CAR T-cell therapy or bispecific antibodies be options for me?

4. What are the side effects I should expect from immunotherapy, and how will you monitor me?

5. Are there clinical trials testing newer immunotherapy combinations that might be appropriate for my situation?

---

Key Takeaway

Immunotherapy is a powerful tool in treating multiple myeloma, especially when combined with other drugs or when myeloma becomes resistant to initial treatment. The approach of using your own immune system to fight cancer offers the potential for more durable responses than some other treatments. However, the specific immunotherapy approach that's right for your situation depends on many factors that only your oncology team can evaluate.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.